Cargando…
Higher serum nerve growth factor levels are associated with major depressive disorder pathophysiology: a case–control study
OBJECTIVE: There is a lack of established biological, psychological, social, and digital markers for the prediction, identification, and stratification of patients with major depressive disorder (MDD). We therefore aimed to evaluate serum nerve growth factor (NGF) in MDD patients. METHODS: In this c...
Autores principales: | Salsabil, Lubaba, Shahriar, Mohammad, Islam, Sardar Mohammad Ashraful, Bhuiyan, Mohiuddin Ahmed, Qusar, MMA Shalahuddin, Islam, Md. Rabiul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107982/ https://www.ncbi.nlm.nih.gov/pubmed/37038918 http://dx.doi.org/10.1177/03000605231166222 |
Ejemplares similares
-
Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study
por: Sohan, Md., et al.
Publicado: (2023) -
Increased serum resistin but not G-CSF levels are associated in the pathophysiology of major depressive disorder: Findings from a case-control study
por: Rahman, Smaranika, et al.
Publicado: (2022) -
Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study
por: Akter, Sarmin, et al.
Publicado: (2023) -
Altered serum interleukin-7 and interleukin-10 are associated with drug-free major depressive disorder
por: Anjum, Sadia, et al.
Publicado: (2020) -
Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study
por: Islam, Salsabil, et al.
Publicado: (2022)